Rifaximin

(Xifaxam®)

Xifaxam®

Drug updated on 11/17/2023

Dosage FormTablet (oral; 200 mg, 550 mg)
Drug ClassRifamycin antibacterial
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for treatment of travelers’ diarrhea (TD) caused by noninvasive strains of Escherichia coli in adult and pediatric patients 12 years of age and older.
  • Indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults.
  • Indicated for treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.